BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25948398)

  • 21. Defensins of
    Bazaliński D; Przybek-Mita J; Lisowicz K; Skórka M; Więch P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceleration of cutaneous wound healing by Lucilia sericata maggots in diabetic Wistar rats.
    Borkataki S; Katoch R; Goswami P; Bhat A; Chakraborty D
    Trop Biomed; 2021 Mar; 38(1):86-93. PubMed ID: 33797529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of a cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme.
    Pritchard DI; Telford G; Diab M; Low W
    Biotechnol Prog; 2012; 28(2):567-72. PubMed ID: 22323388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of the small RNAs in the biomedically important green-bottle blowfly Lucilia sericata.
    Blenkiron C; Tsai P; Brown LA; Tintinger V; Askelund KJ; Windsor JA; Phillips AR
    PLoS One; 2015; 10(3):e0122203. PubMed ID: 25803701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical applications for maggots in wound care.
    Mumcuoglu KY
    Am J Clin Dermatol; 2001; 2(4):219-27. PubMed ID: 11705249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and partial characterization of antifungal bioactivity from the secretions of the medicinal maggot, Lucilia sericata.
    Evans R; Dudley E; Nigam Y
    Wound Repair Regen; 2015; 23(3):361-8. PubMed ID: 25847128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel approach to the antimicrobial activity of maggot debridement therapy.
    Andersen AS; Sandvang D; Schnorr KM; Kruse T; Neve S; Joergensen B; Karlsmark T; Krogfelt KA
    J Antimicrob Chemother; 2010 Aug; 65(8):1646-54. PubMed ID: 20542901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
    Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
    Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome and transcriptome sequencing of the green bottle fly, Lucilia sericata, reveals underlying factors of sheep flystrike and maggot debridement therapy.
    Davis RJ; Belikoff EJ; Dickey AN; Scholl EH; Benoit JB; Scott MJ
    Genomics; 2021 Nov; 113(6):3978-3988. PubMed ID: 34619342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maggot debridement therapy as primary tool to treat chronic wound of animals.
    Choudhary V; Choudhary M; Pandey S; Chauhan VD; Hasnani JJ
    Vet World; 2016 Apr; 9(4):403-9. PubMed ID: 27182137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antibacterial activity of Lucilia sericata maggot secretions.
    Daeschlein G; Mumcuoglu KY; Assadian O; Hoffmeister B; Kramer A
    Skin Pharmacol Physiol; 2007; 20(2):112-5. PubMed ID: 17167275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds.
    Smith AG; Powis RA; Pritchard DI; Britland ST
    Biotechnol Prog; 2006; 22(6):1690-6. PubMed ID: 17137319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary evaluation of maggot (Diptera: Calliphoridae) therapy as a potential treatment for leishmaniasis ulcers].
    Arrivillaga J; Rodríguez J; Oviedo M
    Biomedica; 2008 Jun; 28(2):305-10. PubMed ID: 18719732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sterilization of Lucilia sericata (Diptera: Calliphoridae) Eggs for Maggot Debridement Therapy.
    Bavani MM; Seyyedzadeh SJ; Radi E; Malekian A; Hoseinpour M; Gholizadeh S
    J Med Entomol; 2022 May; 59(3):1076-1080. PubMed ID: 35187572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maggot chymotrypsin I from Lucilia sericata is resistant to endogenous wound protease inhibitors.
    Telford G; Brown AP; Kind A; English JS; Pritchard DI
    Br J Dermatol; 2011 Jan; 164(1):192-6. PubMed ID: 21175562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth and survival of blowfly Lucilia sericata larvae under simulated wound conditions: implications for maggot debridement therapy.
    Čičková H; Kozánek M; Takáč P
    Med Vet Entomol; 2015 Dec; 29(4):416-24. PubMed ID: 26382290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Maggot therapy with Lucilia sericata for debridement of chronic wounds].
    Cartier E; Combemale P
    Ann Dermatol Venereol; 2008 Oct; 135(10):685-8. PubMed ID: 18929922
    [No Abstract]   [Full Text] [Related]  

  • 38. Maggot Therapy in Wound Healing: A Systematic Review.
    Mohd Zubir MZ; Holloway S; Mohd Noor N
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32825736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excretions/secretions from medicinal larvae (Lucilia sericata) inhibit complement activation by two mechanisms.
    Tamura T; Cazander G; Rooijakkers SH; Trouw LA; Nibbering PH
    Wound Repair Regen; 2017 Jan; 25(1):41-50. PubMed ID: 28019718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel family of insect salivary inhibitors blocks contact pathway activation by binding to polyphosphate, heparin, and dextran sulfate.
    Alvarenga PH; Xu X; Oliveira F; Chagas AC; Nascimento CR; Francischetti IM; Juliano MA; Juliano L; Scharfstein J; Valenzuela JG; Ribeiro JM; Andersen JF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2759-70. PubMed ID: 24092749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.